Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | January 3, 2024 |
| Target | AbCheck |
| Sector | Life Science |
| Buyer(s) | Ampersand Biomedicines |
| Sellers(s) | Affimed Therapeutics AG |
| Deal Type | Divestiture |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2021 |
| Sector | Medical Products |
Ampersand Biomedicines is a multi-product platform company developing smarter medicine products. Ampersand Biomedicines was founded in 2021 and is based in Boston, Massachusetts.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| Country: Czech Republic | 1 of 1 |
| Year: 2024 | 1 of 1 |
Affimed Therapeutics AG develops Human antibody therapeutics.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| Country: Czech Republic | 1 of 1 |
| Year: 2024 | 1 of 1 |